Emcure Pharma IPO listing is scheduled for tomorrow, Wednesday, July 10, 2024. The IPO allotment was finalized on Monday, July 8, 2024. For those who have been allocated shares, the shares will be credited to their demat accounts today, Tuesday, July 9. Additionally, the refund process for those who did not receive shares will also be completed today. Here’s what you need to know about the Emcure Pharma IPO listing tomorrow.
Emcure Pharma IPO Listing Tomorrow
On the final day of subscription, Friday, July 5, Emcure Pharma IPO received 67.84 times the number of subscriptions, according to BSE data. The qualified institutional buyer (QIB) segment was oversubscribed 195.83 times, while the non-institutional investor quota saw 48.28 times subscriptions. The retail individual investor (RII) quota was oversubscribed 7.17 times, and the employee quota received 8.78 times subscriptions. The IPO, which opened on Wednesday, July 3, had a price band set between INR 960 – 1,008 per share.
In the Emcure Pharma IPO, 15% of the shares are allocated for non-institutional investors (NII), 35% are designated for retail investors, and 50% are reserved for qualified institutional buyers (QIB). Additionally, shares are reserved for employees, who are also being offered nearly a 9% discount.
Emcure Pharma IPO GMP
Investors are also considering the market opportunity and the unique premium of the Indian pharmaceutical company about to enter the market. Consequently, there is a significant grey market premium (GMP), offering a profit potential. Let’s examine what the GMP for Emcure Pharma IPO has indicated in the last few days ahead of its listing.
Over the past nine days (June 29 – July 9), the average grey market premium (GMP) for Emcure Pharma IPO was INR 308 per share, with today’s GMP being at INR 360 per share, according to IPOCentral’s GMP tracker. Accordingly, the anticipated listing price for Emcure Pharma IPO is pegged at INR 1,368 per share. This figure represents a potential profit of 35.71% from the IPO price of INR 1,008 per share, factoring in the upper limit of the IPO pricing range and the current premium observed in the grey market.
The term “Grey market premium” signifies the willingness of investors to pay a price higher than the initial offering price. While trading in this parallel market is not recognized by stock exchanges, the grey market has worked reasonably well to anticipate listing prices. Most recently, shares of Allied Blenders & Distillers and Stanley Lifestyles had strong starts on their stock market debuts, as indicated by the grey market.
Emcure Pharma IPO Details
Emcure Pharma’s IPO subscription commenced on July 3, 2024, and concluded on July 5, 2024. The IPO is to raise approximately INR 1,952.03 crores, comprising a fresh issue of INR 800 crore and an offer-for-sale (OFS) of 1,14,28,839 shares by the promoters and shareholders. The price band for the IPO is fixed at INR 960 – 1,008 per share. The market lot for Emcure Pharma IPO is 14 shares, with a minimum application amount of INR 14,112.
Emcure Pharmaceuticals is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company has a differentiated product portfolio that includes orals, injectables, and biotherapeutics, with a strong presence in India, Europe, and Canada.
Analysts believe the company has scope for business improvement on the back of industry tailwinds and business scalability. The global pharmaceutical market is expected to grow at a CAGR of 5.0 -5.5% between 2023-2028 to reach USD 1.9-1.95 trillion.
Emcure Pharma IPO Listing FAQs
What are Emcure Pharma IPO dates?
Emcure Pharma’s IPO subscription commenced on July 3, 2024, and concluded on July 5, 2024.
When is the Emcure Pharma IPO listing expected?
Emcure Pharma IPO listing date is Wednesday, July 10, 2024.
Can we buy an IPO on the listing date?
You can place a buy order at a desired price for the IPO shares on the listing day after 10 AM.
